Shanghai Yizhong Pharmaceutical Co., Ltd.

Chinese biotech developing and selling micelle-based anti-cancer drugs

What Shanghai Yizhong Pharmaceutical does

Shanghai Yizhong develops cancer drugs in China. Its main product is paclitaxel polymer micelles for injection, a new form of the well-known chemotherapy drug paclitaxel. It is approved for non-small cell lung cancer, and the company is studying it for other cancers as well.

How Shanghai Yizhong Pharmaceutical makes money

The company makes money by selling its paclitaxel polymer micelle injection to hospitals and patients in China. It also puts money into research to use the drug for more cancer types.

Products & services

• Paclitaxel polymer micelles for injection
• Paclitaxel micelle therapy for non-small cell lung cancer
• Anti-tumor drug R&D pipeline